Date Filed | Type | Description |
12/26/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/17/2012 |
3
| FRANCO RICHARD A (Director) has filed a Form 3 on Islet Sciences, Inc |
06/13/2012 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on METROPOLITAN HEALTH NETWORKS INC
Txns:
| Granted 9,069 shares
@ $0 |
|
04/09/2012 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD
Txns:
| Granted 4,160 shares
@ $0 |
|
03/20/2012 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD
Txns:
| Sold 9,375 shares
@ $51.98, valued at
$487.3k
|
|
01/10/2012 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/05/2012 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD
Txns:
| Paid exercise price by delivering 1,439 shares
@ $47.85, valued at
$68.9k
|
|
07/06/2011 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD
Txns:
| Paid exercise price by delivering 1,352 shares
@ $39.83, valued at
$53.9k
|
|
05/26/2011 |
SC 13D/A
| DARA BioSciences, Inc. reports a 5.6% stake in DARA BioSciences, Inc. |
05/16/2011 |
4
| FRANCO RICHARD A (President & CEO) has filed a Form 4 on DARA BioSciences, Inc.
Txns:
| Converted 80,000 shares
@ $2.5, valued at
$200k
Converted 200 options to buy
@ $2.5, valued at
$500 |
|
05/04/2011 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD
Txns:
| Granted 4,640 shares
@ $0 |
|
04/26/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/08/2011 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD
Txns:
| Exercised 15,000 options to buy
@ $17.63, valued at
$264.5k
Exercised 22,500 options to buy
@ $18.8733, valued at
$424.6k
|
|
01/06/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/03/2011 |
4
| FRANCO RICHARD A (President & CEO) has filed a Form 4 on DARA BioSciences, Inc.
Txns:
| Bought 200 convertible preferred
@ $2.5, valued at
$500 |
|
09/08/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/03/2010 |
4
| FRANCO RICHARD A (President & CEO) has filed a Form 4 on DARA BioSciences, Inc. |
08/31/2010 |
4
| FRANCO RICHARD A (President & CEO) has filed a Form 4 on DARA BioSciences, Inc. |
08/30/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/21/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/21/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/06/2010 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD
Txns:
| Paid exercise price by delivering 3,770 shares
@ $39.03, valued at
$147.1k
|
|
05/24/2010 |
4
| FRANCO RICHARD A (President & CEO) has filed a Form 4 on DARA BioSciences, Inc. |
05/19/2010 |
4
| FRANCO RICHARD A (President & CEO) has filed a Form 4 on DARA BioSciences, Inc. |
05/05/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/28/2010 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on METROPOLITAN HEALTH NETWORKS INC
Txns:
| Granted 11,978 shares
@ $0 Granted 5,989 options to buy
@ $3.04, valued at
$18.2k
|
|
04/28/2010 |
3
| FRANCO RICHARD A (Director) has filed a Form 3 on METROPOLITAN HEALTH NETWORKS INC |
02/12/2010 |
4
| FRANCO RICHARD A (President & CEO) has filed a Form 4 on DARA BioSciences, Inc. |
02/02/2010 |
4
| FRANCO RICHARD A (President & CEO) has filed a Form 4 on DARA BioSciences, Inc.
Txns:
| Granted 1,000,000 options to buy
@ $0.46, valued at
$460k
|
|
09/28/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/18/2009 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
07/06/2009 |
4
| FRANCO RICHARD A (Director) has filed a Form 4 on SALIX PHARMACEUTICALS LTD |
02/02/2009 |
3
| FRANCO RICHARD A (CEO) has filed a Form 3 on DARA BioSciences, Inc. |
03/13/2008 |
SC 13D
| Form SC 13D -- General statement of acquisition of beneficial ownership |